PT - JOURNAL ARTICLE AU - Y.B.A. Wan AU - M.A. Simpson AU - J.A. Aragon-Martin AU - D.P.S. Osborn AU - E. Regalado AU - D.C. Guo AU - C. Boileau AU - G. Jondeau AU - L. Benarroch AU - Y. Isekame AU - J. Bharj AU - J. Sneddon AU - E. Fisher AU - J. Dean AU - M.T. Tome Esteban AU - A. Saggar AU - D. Milewicz AU - M. Jahangiri AU - E. R. Behr AU - A. Smith AU - A. H. Child TI - A mutation in the <em>LMOD1</em> actin-binding domain segregating with disease in a large British family with thoracic aortic aneurysms and dissections AID - 10.1101/153452 DP - 2017 Jan 01 TA - bioRxiv PG - 153452 4099 - http://biorxiv.org/content/early/2017/07/14/153452.short 4100 - http://biorxiv.org/content/early/2017/07/14/153452.full AB - We describe a mutation in LMOD1, which predisposes individuals to thoracic aortic aneurysms and dissections in a large multi-generation British family. Exome variant profiles for the proband and two distantly related affected relatives were generated and a rare protein-altering, heterozygous variant was identified, present in all the exome-sequenced affected individuals. The allele c.1784T&gt;C, p.(V595A) in LMOD1 is located in a known actin-binding WH2 domain and is carried by all living affected individuals in the family. LMOD1 was further assessed in a consecutive series of 98 UK TAAD patients and one further mutation was found, yielding an incidence of ∼2% in our study group. Assessment of LMOD1 in international TAAD cohorts discovered nine other missense variants of which three were classed as likely pathogenic.Validation of LMOD1 was undertaken using a zebrafish animal model. Knock-down of both lmod1a and lmod1b paralogs using morpholino oligonucleotides showed a reproducible abnormal phenotype involving the aortic arches under off-target controls. Injection of the human LMOD1 c.1784T&gt;C, p.(V595A) mutation demonstrated a likely dominant negative effect and illustrated a loss of function cause.Mutations found in the WH2 actin-binding domain of LMOD1 may delay actin polymerization and therefore compromise actin length, dynamics and interaction with myosin in the smooth muscle contraction pathway.